PDPN and cancer: Our observation agrees with several studies which demonstrated involvement of podoplanin in cell migration and invasiveness during cancer progression, and in the promotion of epithelial-mesenchymal transition through down-regulation of epithelial genes and up-regulation of mesenychymal markers [16], [55], [56].